Analyst Coverage

The following analysts compile research on 4SC:

Edison Investment Research Limited

Linda Pomeroy, Ph.D.
280 High Holborn
London WC1V 7EE
United Kingdom

Phone: +44 20 3077 5738

equinet Bank AG

Marietta Miemietz
Gräfstraße 97
60487 Frankfurt am Main

Phone: +49 69 58997 439


Thomas J. Schießle
Am Schieferstein 1
60435 Frankfurt am Main

Phone: +49 69 9545 4360

Executive interview – 4SC

Executive interview – 4SC | 10/08/2017

4SC is a Munich-based cancer biopharmaceutical company. In this interview Jason Loveridge, CEO of 4SC, provides an overview of the company, its recent…

A streamlined focus moving forward

4SC | 30/03/2017

2016 was an important year for 4SC as it launched its potentially pivotal Phase II study with resminostat, an epigenetic cancer drug, in CTCL. In addition,…

Share this page:

Follow us on: